Objective. To review the evidence for the effectiveness of exercise therapy and to estimate the additional effect of supervision on exercise therapy in patients with intermittent claudication. Materials and methods. A systematic review was performed of all randomised controlled trials (RCTs) comparing supervised exercise therapy to unsupervised exercise regimens or observation in patients with intermittent claudication. Main endpoints were pain free walking distance (PWD) and absolute walking distance (AWD). Quality assessment and data extraction were performed independently by two observers. Results. Fifteen manuscripts, published between 1990 and May 2006, were eligible for analysis, evaluating 761 patients. In the studies comparing supervised exercise to standard care the weighted mean difference in pain free walking distance (PWD) and absolute walking distance (AWD) was 81.3 meters (95% CI; 35.5e127.1) and 155.8 meters (95% CI; 80.8e 230.7), respectively. In the studies comparing supervised to unsupervised exercise therapy, the weighted mean difference in PWD and AWD was 143.8 meters (95% CI; 5.8e281.8) and 250.4 meters (95% CI;. Conclusion. Exercise therapy increases the PWD and AWD in patients with intermittent claudication. Supervised exercise therapy increases the PWD and AWD more than standard care. However, the additional value of supervision over unsupervised exercise regimens needs further clarification.
Introduction
Intermittent claudication is a life-style limiting manifestation of peripheral arterial occlusive disease. The age-adjusted prevalence is approximately 12 percent and increases to 20 percent if only patients older than 70 years are considered. 1 Current treatment is aimed at risk factor modification, improvement of quality of life by relieving symptoms, or more invasive approaches such as angioplasty or surgery. The choice for one or more of the above mentioned modalities depends on the localisation and extent of the vascular lesion(s), and the patient's co-morbidity and preferences.
Exercise therapy is an inexpensive, low risk treatment compared to radiological or surgical interventions. Several mechanisms for the reported benefits of (supervised) exercise therapy have been proposed. These mechanisms include increased collateral blood flow and redistribution, changes in microcirculation and endothelial function, improved oxidative metabolism and oxygen extraction, beneficial influences on haemo-rheological factors, improved walking economy, conditioning and favourable effects on risk factors. 1 Several exercise regimes have been investigated, all including short periods of walking or other forms of exercise inducing discomfort or pain, interspersed with short periods of rest. These cycles are performed up to one hour and repeated three to five times per week. Exercise therapy can be performed by patients individually after an instruction session, or under supervision. The addition of supervision is proposed to have a favourable effect on walking distance as compared to unsupervised exercise therapy.
In a systematic review of uncontrolled cohort studies, Gardner et al. found that supervised exercise therapy improved the pain free and maximum walking time with 180% and 120%, respectively. 2 They concluded that exercise therapy should comprise intermittent walking to near maximal pain for at least 30 minutes with a minimum of three sessions per week, for at least 6 months. A Cochrane review including randomised and clinical controlled trials comparing supervised exercise therapy to non-supervised exercise therapy found an improvement in walking ability of approximately 150 meters. 3 Since then, more randomised trials evaluating supervised exercise versus non supervised exercise or standard care have been published. However, despite all available data, uncertainty remains as to whether supervised exercise therapy has additional value over unsupervised regimens, and also about the optimal intensity and duration of exercise programmes.
The aim of this systematic review was to assess the effects of exercise therapy compared to standard care on pain free and absolute walking distance in patients with intermitted claudication due to peripheral arterial occlusive disease. Secondly, the additional benefit of supervision during exercise therapy was evaluated.
Materials and Methods

Literature search
The Cochrane Database of systematic reviews, the Cochrane central register of controlled trials, the ACP journal club, the database of abstracts of reviews of effects (DARE), Medline, and Embase databases were searched by using the MESH headings and keywords ''claudication'', ''intermittent claudication'', ''exercise'', ''exercise therapy'' and ''randomized OR randomised'' to identify randomised trials published between 1966 and May 2006. Two investigators (MK, JW) independently performed the literature search. Electronic links to related articles and references of selected articles were hand-searched as well. Leading investigators in the field were contacted to inquire whether studies were missed or publications were recently submitted. A hand search of relevant journals and conference proceedings was not performed. We did not use a language restriction.
Study selection and data extraction
From the potentially eligible studies only randomised trials were included comparing supervised exercise therapy and unsupervised exercise regimens, or observation in patients with intermittent claudication from peripheral arterial occlusive disease. Studies were included if they presented data as pain free walking distance (PWD) and/or absolute walking distance (AWD) expressed in meters and the standard deviation, or if these data could be derived from the original paper. The same investigators independently extracted data from the trials including age, proportion of male subjects, other treatment apart from intervention, (supervised) exercise regimen, control regimen, duration of intervention, complications related to exercise, and drop-out rate. If necessary data could not be abstracted from the original publications, corresponding authors were contacted and asked to provide these data. Duplicate publications were excluded. If papers repeatedly reported on (parts of) the same study population, only the first publication was included. Each of the selected trials was critically appraised by the two investigators, using a critical review checklist for study validity as proposed by the Dutch Cochrane Collaboration. 4 Data were extracted from original publications only. Final inclusion was done after consensus was reached. Discrepancies in judgement, if any, were resolved by discussion.
Analysis and presentation of data
The PWD and AWD were expressed as meters AE standard deviation (SD). In case the PWD and AWD were reported as times, these were transformed to meters AE SD with the help of the reported walking speed, however irrespective of the slope of the treadmill. Quantitative data were entered into the Cochrane Review Manager 4.2 software and analysed using RevMan Analyses 1.0.2 (The Cochrane Collaboration, Oxford, UK).
5 Statistical heterogeneity was tested using Chisquare and I-square statistics. Data were pooled using a fixed effects model if heterogeneity was limited, the random effects model was used when heterogeneity was apparent. Summary estimates of treatment effects, including 95% confidence intervals (CI), were calculated for each comparison. For the continuous outcome data, i.e. PWD and AWD, means and SD were used to calculate a weighted mean difference (WMD) in the meta-analysis.
Results
Included studies
The searches identified 8 systematic reviews that were used for retrieving additional studies. 2,3,6e11 The search identified a total of 28 original publications. Fourteen of these 28 publications were excluded; two controlled clinical trials without random treatment allocation 12, 13 ; one study comparing two supervised regimes with different intensity 14 ; 3 studies were excluded because either part or all of the data had been used in other publications, 15e17 and 8 studies were excluded because of insufficient details or unclear reporting. 18e25 In four of these studies the reason for exclusion was that the SD of the mean PWD and AWD was not reported. Fortunately, two authors of other studies provided such data on request. 26, 27 One additional study was identified after personal communication. 28 Our definitive analysis comprised 15 studies that were published between 1990 and 2006 and reported on a total of 761 randomised patients, with a range of 14 to 149 patients per study.
26e41 Table 1 lists the study design, while in Table 2 the quality assessment of the included studies is presented. The included studies had several limitations. There were only small single-centred studies and although all studies were randomised controlled trials, only few provided details about the process of randomisation. Attempts to minimise bias by concealment of allocation, 27 or blinding of the assessor to the allocated treatment when patients underwent their final testing 38 were sparse. Nearly half of the manuscripts reported that the results were analysed on an intention to treat basis.
Exercise-and control regimens
Ten studies compared supervised exercise therapy with standard care (observation and/or medication). The control-patients in the other 5 studies received unsupervised exercise therapy, in general consisting of instructions only ( Table 3) . Most of the supervised exercise regimens lasted 12-26 weeks with a frequency of 2 to 3 times per week. In the study by Jansen et al. the supervised exercise regime lasted 2 years. 41 Dropout rates, after randomisation ranged between the 0 and 50%. Most of the drop-outs were related to medical reasons or refusal by the patient to continue in the programme. Similar drop-out rates were reported in the control groups, also related to medical reasons or patient refusal. Few patients participating in the trials experienced adverse effects. Only one study reported an 8% complication rate consisting of minor leg injury. 27 In the other studies complication rates were not reported or there were no complications.
Pain free-(PWD) and absolute walking distance (AWD) Table 4 lists the PWD and AWD on entry and after the intervention. In the studies comparing supervised exercise therapy versus standard care change in PWD and AWD ranged from 32 to 230 meters and from À11 to 306 meters, respectively in the supervised exercise group and from À38 to 40 meters and from À19 to 74 meters, respectively in the control group. In the studies comparing supervised versus unsupervised exercise therapy the change in PWD and AWD ranged from 32 to 339 meters and from 184 to 491 meters respectively in the supervised exercise group and from À2 to 99 meters and from À5 to 205 meters respectively in the control group.
Although there was evidence of clinical and statistical heterogeneity we decided to pool the individual study results because all effects of the intervention were in the same direction. Fig. 1 shows the results for the effect of exercise therapy on PWD. In the 8 studies that compared supervised exercise to standard care the WMD in PWD was 81.29 meters (95% CI; 35.45-127.14) in favour of exercise therapy. In the 4 studies comparing supervised to unsupervised exercise therapy the WMD in PWD was 143.81 meters (95% CI; 5.81-281.81) in favour of the supervised regimen. The WMD of all 12 studies comprising 522 patients (supervised exercise versus unsupervised or standard care) was 94.65 meters (95% CI; 54.78e134.52). Fig. 2 shows the results for the effect of exercise therapy on AWD. In the 9 studies that compared supervised exercise to standard care, the WMD in AWD was 155.79 meters (95% CI; 80.84-230.74). In the 5 studies comparing supervised to unsupervised exercise therapy the WMD in AWD was 250.40 meters (95% CI; 192. 35-308.45 ). The WMD of all the 14 studies comprising 626 patients (supervised exercise versus unsupervised or standard care) was 171.75 meters (95% CI; 106.70-236.81).
Discussion
The objective of this review was to assess the evidence of exercise therapy and to estimate the additional effect of supervision on exercise therapy in patients with intermittent claudication, to provide high level evidence that may help future health care planning. Many vascular surgeons do not have access to a rehabilitation centre for carrying out supervised exercise therapy. The results of our study could influence daily practice as it might be that the choice between supervised or unsupervised exercise therapy mainly is based on economic and logistic factors, rather than on scientific data. Our systematic review and meta-analysis indicate that supervised exercise therapy increases the PWD and AWD in patients with intermittent claudication. Whether supervision has additional value over simple exercise instructions remains a matter of debate. In the studies comparing supervised to unsupervised exercise therapy, both PWD and AWD were increased; 143.81 meters (95% CI; 5.81-281.81) and 250.40 meters (95% CI; 192.35-308.45) respectively. One would expect that the differences between supervised exercise and standard care would be more pronounced. However this was not seen in the pooled result of the studies comparing supervised exercise to standard care; the WMD in PWD and AWD was 81.29 meters (95% CI; 35.45-127.14) and 155.79 meters (95% CI; 80.84-230.74), respectively. Most of the included studies applied an exercise regimen of 2-3 times a week. The optimal intensity of training is not clear although it has been suggested that patients exercise until near maximal pain. Interestingly, in a recent study no differences were found between patients training at 40% or 80% of their maximal intensity.
14 In addition, 
O: yes; -: no or not (adequately) reported; y Intervention group received additional exercise instructions for at home; z Numbers given, not reasons; * Only abstract available.
the optimal duration of and type of exercise therapy remains uncertain. Most studies reported short-term effects only, and the maximum duration of exercise therapy in the included studies was 6 months with the exception of one study. 41 Alternative training therapies have been proposed including individualized home based training programmes which are guided by the pain threshold. These programmes are a compromise between supervised physical training and mere advice to get more exercise. The pain threshold is used to guide the exercise therapy, prescribed at the hospital and performed at home. 42 These programmes have not been evaluated thoroughly.
Our systematic review has many limitations; the overall methodological quality of the included studies was moderate with several sources of bias, limiting the level of evidence of this systematic review. Only few studies provided details about the process of randomisation, or used allocation concealment and assessor blinding to minimise bias. In addition, nearly all studies had a very small sample size. Although metaanalysis is a powerful tool to identify possible differences in efficacy of a treatment, it would have been preferable if the original studies had been adequately powered to enable the detection of such differences.
The generalisability of the individual single-centre study results is unclear. In addition, the majority of Table 1 ).
data on supervised exercise therapy were obtained from the same few centers. Furthermore, the included studies applied various exclusion criteria, such as cardiac or pulmonary impairment, diabetes, smoking behaviour, and even use of antiplatelet drugs. Finally, few studies described the localisation and severity of peripheral arterial disease. It is therefore likely that there was considerable heterogeneity between study populations, which is reflected by the wide range in baseline PWD and AWD. The fact that nearly all studies reported positive results could be an indication of publication bias. This probably applies particularly to Exercise Therapy and the Additional Effect of Supervision on Exercise Therapy the studies using unsupervised exercise therapy as control, as in these studies a larger than expected treatment effect was found. Although we did not systematically look for unpublished studies, we tried to include as many studies as possible by contacting authors when data were lacking, to maximise the number of studies and patients in our analysis. We chose to express the primary outcome as the distance in meters, as we thought this would yield more information than a relative change in walking distance. This required calculation of distances when studies reported walking ability as time until onset of pain or maximum walking time. In all studies, the final assessment was done on a treadmill with varying speed and slope, and sometimes even an incremental speed was used. It is likely that such heterogeneous ways of testing imply that walking distances are not fully comparable. It has been suggested that the shuttle walking test is a more representative and better reproducible test to evaluate intermittent claudication, 40 but this test was not used. A relative change could be more important, since doubling of walking distance could benefit a person with a very limited walking distance, although this might be better expressed through quality of life evaluations. Unfortunately, quality of life was reported in only a few studies.
It is possible that the results can be explained partially by the Hawthorne effect. The Hawthorne effect describes the effect that the awareness of being under observation can alter the way a patient behaves or positively influence the outcome of a study as the control patients in some of the studies showed an increase in walking distance at the end of the study period. 43 So, after 15 randomised trials including only 761 patients, and 8 systematic reviews on this topic, we know that exercise therapy increases the PWD and AWD in patients with intermittent claudication. We also know that supervised exercise therapy increases the PWD and AWD more than standard care. However, the additional value of supervision over unsupervised exercise regimens needs to be clarified. No optimal exercise regimen could be extracted from our analysis. Thus, more multi-centre prospective randomised trials are needed to confirm the preliminary results of supervised exercise training in patients with intermittent claudication.
